Neuroprotection by a bradykinin B2 receptor antagonist after traumatic brain injury is not attenuated by the simultaneous application of a bradykinin B1 receptor antagonist

被引：0
|
作者：
Görlach, C
Hortobágyi, T
Hortobágyi, S
Benyó, Z
Relton, JK
Whalley, ET
Wahl, M
机构：
[1] Univ Munich, Dept Physiol, D-8000 Munich, Germany
[2] Semmelweis Univ, Dept Expt Res, Inst Physiol 2, H-1085 Budapest, Hungary
[3] Biogen Inc, Cambridge, MA 02142 USA
来源：
JOURNAL OF PHYSIOLOGY-LONDON | 2000年 / 526卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：50P / 51P
页数：2
相关论文
共 50 条
  • [21] Antagonist-induced intracellular sequestration of the rabbit bradykinin B2 receptor
    Bachvarov, D
    Houle, S
    Larrivée, JF
    Bachvarova, M
    Bouthillier, J
    Marceau, F
    FASEB JOURNAL, 2000, 14 (08): : A1353 - A1353
  • [22] Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant
    Del Corso, I.
    Puxeddu, I.
    Sardano, E.
    Geraci, S.
    Breggia, M.
    Rocchi, V.
    Migliorini, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 108 (06) : 460 - 461
  • [23] A rational approach to the design and synthesis of a new bradykinin B1 receptor antagonist
    Bedos, P
    Amblard, M
    Subra, G
    Dodey, P
    Luccarini, JM
    Paquet, JL
    Pruneau, D
    Aumelas, A
    Martinez, J
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (12) : 2387 - 2394
  • [24] Discovery of a potent, non-peptide bradykinin B1 receptor antagonist
    1600, American Chemical Society (125):
  • [25] A selective Bradykinin B1 receptor antagonist attenuates diabetic hyperalgesia in rats
    Benrezzak, O
    Gabra, BH
    Guerin, B
    Neuebaueur, W
    Sirois, P
    Battistini, B
    Nantel, F
    DIABETES, 2004, 53 : A119 - A119
  • [26] Discovery of a potent, non-peptide bradykinin B1 receptor antagonist
    Su, DS
    Markowitz, MK
    DiPardo, RM
    Murphy, KL
    Harrell, CM
    O'Malley, SS
    Ransom, RW
    Chang, RSL
    Ha, S
    Hess, FJ
    Pettibone, DJ
    Mason, GS
    Boyce, S
    Freidinger, RM
    Bock, MG
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (25) : 7516 - 7517
  • [27] Induction of B1 bradykinin receptors with lipopolysaccharide treatment in B2 bradykinin receptor knockout mice
    Shepheard, SL
    Cook, DA
    Hargreaves, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126
  • [28] Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from brain oedema, postischaemic inflammation and cerebral infarction
    Austinat, M. L.
    Braeuninger, S.
    Stoll, G.
    Renne, T.
    Kleinschnitz, C.
    JOURNAL OF NEUROLOGY, 2008, 255 : 49 - 49
  • [29] Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply
    Ian Roberts
    Haleema Shakur
    Trials, 10
  • [30] The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling
    Bonde, Marie Mi
    Olsen, Kristine Boisen
    Erikstrup, Niels
    Speerschneider, Tobias
    Lyngso, Christina
    Haunso, Stig
    Nielsen, Morten Schak
    Sheikh, Soren P.
    Hansen, Jakob Lerche
    REGULATORY PEPTIDES, 2011, 167 (01) : 21 - 25
12345